Business Segments · Sales to customers (Note 9)
MEDTECH — Sales to customers (Note 9)
Johnson & Johnson MEDTECH — Sales to customers (Note 9) decreased by 1.9% to $8.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $8.02B to $8.64B. Over 4 years (FY 2021 to FY 2025), MEDTECH — Sales to customers (Note 9) shows an upward trend with a 5.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 22, 2026
Rolls up toTotal Revenue
How to read this metric
Higher sales indicate strong market adoption and successful commercial execution.
Detailed definition
Represents the total revenue generated from the sale of medical devices and related services to external customers. This...
Peer comparison
The standard revenue metric for all public companies.
Metric ID:
jnj_segment_medtech_sales_to_customers_note_9Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.98B | $6.64B | $6.86B | $6.97B | $6.90B | $6.78B | $6.78B | $7.48B | $7.79B | $7.46B | $7.67B | $7.82B | $7.96B | $7.89B | $8.19B | $8.02B | $8.54B | $8.43B | $8.80B | $8.64B |
| QoQ Change | — | -4.8% | +3.2% | +1.6% | -1.0% | -1.7% | -0.1% | +10.4% | +4.1% | -4.2% | +2.9% | +1.9% | +1.7% | -0.8% | +3.8% | -2.1% | +6.5% | -1.3% | +4.4% | -1.9% |
| YoY Change | — | — | — | — | -1.1% | +2.1% | -1.2% | +7.3% | +12.9% | +10.0% | +13.2% | +4.5% | +2.2% | +5.8% | +6.7% | +2.5% | +7.3% | +6.8% | +7.5% | +7.7% |
Range$6.64B – $8.80B
CAGR+4.6%
Avg YoY Growth+5.9%
Median YoY Growth+6.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported medtech — sales to customers (note 9) of $8.64B in Q1 2026.
- How has Johnson & Johnson's medtech — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's medtech — sales to customers (note 9) increased by 7.7% year-over-year, from $8.02B to $8.64B.
- What is the long-term trend for Johnson & Johnson's medtech — sales to customers (note 9)?
- Over 4 years (2021 to 2025), Johnson & Johnson's medtech — sales to customers (note 9) has grown at a 5.7% compound annual growth rate (CAGR), from $27.06B to $33.79B.
- What does medtech — sales to customers (note 9) mean?
- The total revenue earned from selling medical devices to customers.